EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Novel nonmagnetic abutment designs for facial prostheses: an experimental study

İREM SOZEN YANİK, UFUK ADALİ, JAMILA YASSINE, FRANSIZKA SCHMIDT, WOLFGANG HANNAK, BAHADIR ERSU

Turkish Journal of Medical Sciences · 2025-02-18 · 55 (1) · 152-160

DOI: 10.55730/1300-0144.5953 ↗
AstrattDettalji biblijografiċi

Astratt

Background/aim: This in vitro study aimed to evaluate and compare the retentive forces of novel nonmagnetic abutment designs developed as an alternative to conventional magnetic abutments for facial prostheses.Materials and methods: A plexiglass model was constructed and two extraoral implants were placed in these blocks in a parallel position. Nonmagnetic abutments made of titanium were fabricated and screwed onto the implants. The nonmagnetic systems represent a novel design and include two different abutment designs (Type 1 and Type 2) with silicone attachments. Retentive force values for three abutment types: Conventional Magnetic System (CMS), Nonmagnetic abutment Type 1 System (NMS1), and Nonmagnetic abutment Type 2 System (NMS2) were measured at 0th, 120th, 360th, 720th, and 1440th dislodging cycles using a test machine. Given the data's distribution characteristics, non-parametric tests were used for analysis. The Kruskal-Wallis test evaluated significant differences among groups, followed by Dunn's post-hoc test for specific group comparisons. The Friedman test compared the number of dislodging cycles for each group, and the Benjamini-Hochberg adjusted Wilcoxon sign-rank test was used for pairwise comparisons.Results: Both NMS1 and NMS2 groups exhibited significantly higher retentive forces compared to CMS for each of the same dislodging cycles (p

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →